Rise Therapeutics, LLC
4:30 PM - 4:45 PM (EDT), Monday, June 5, 2023 ・ Session Room 104C
Rise Therapeutics is a clinical-stage developer of targeted oral immunotherapy drugs that leverages its product development experience and clinical GMP manufacturing infrastructure to develop novel synthetic biology-based cellular immune medicines.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Maryland
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Immunology
Lead Product in Development:
R-3750
R-2487
R-5780
Development Phase of Primary Product:
Phase I
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
